Citadel Advisors’s Pfenex Inc. PFNX Stock Holding History

Citadel Advisors’s Portfolio PFNX Stock Details PFNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-15,200	Closed	-$127K	–	11101
2020 Q2	$127K	Sell	15,200 -1,700	-10%	-$12.7K	﹤0.01%	8861
2020 Q1	$149K	Buy	16,900 +6,500	+63%	+$71.4K	﹤0.01%	8306
2019 Q4	$114K	Buy	+10,400	New	+$103K	﹤0.01%	8495
2018 Q4	–	Sell	-28,900	Closed	-$148K	–	10081
2018 Q3	$148K	Buy	28,900 +13,400	+86%	+$68.8K	﹤0.01%	8404
2018 Q2	$84K	Buy	+15,500	New	+$89.6K	﹤0.01%	8309

Other funds holding PFNX

IRAG

Investment Research & Advisory Group Atlanta, Georgia $324M AUM 22.57% 1-Year Est. Return

Citadel Advisors's PFNX Position: Q4 2020 in Review

Citadel Advisors sold out of Pfenex Inc. (PFNX) in Q4 2020, closing a stake of 23,562 shares — an estimated $300K sold.

Citadel Advisors first reported a position in PFNX in Q2 2015 and held it in 7 quarters. The position peaked at $1.05M in Q2 2015. 1 fund tracked by Wall St. Rank holds PFNX as of Q4 2020.

Citadel Advisors reported no remaining Pfenex Inc. position as of Q4 2020 after selling out during the quarter.
Citadel Advisors sold 23,562 Pfenex Inc. shares in Q4 2020, an estimated $300K.
Citadel Advisors first reported a position in Pfenex Inc. in Q2 2015 and held it in 7 quarters.
Citadel Advisors's Pfenex Inc. position peaked at $1.05M in Q2 2015.
1 fund tracked by Wall St. Rank held Pfenex Inc. as of Q4 2020.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.